Kuntz Richard 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 2, 2024
Insider Transaction Report
Form 4
Kuntz Richard
Director
Transactions
- Award
Voting Common Shares, no par value per share
2024-01-02$2.80/sh+14,285$39,998→ 14,285 total
Footnotes (1)
- [F1]These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $40,000. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.